Predicción y previsión de precio de Abivax SA (ABVX)ABVXAbivax SA

Alphio's ABVX stock price prediction model matches the current Abivax SA tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $115.02 (+1.47%). The 1-week path is $115.87 (+2.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Abivax SA is a good buy right now due to its recent funding of $920 million, which supports the U.S. launch of its drug obefazimod, and the positive analyst ratings with targets up to $180. The current RSI of 27.033 indicates the stock is oversold, suggesting a potential rebound. However, the main risk is the negative forward P/E ratio of 0, indicating uncertainty in future earnings performance.

Abivax SA (ABVX) last closed at $113.35, losing -0.83%. These facts feed the 1-day and 1-week ABVX price prediction above.